Details of the Drug Inactive Ingredient (DIG)
General Information of DIG (ID: E0ST5E) | |||||
---|---|---|---|---|---|
DIG Name |
Pregelatinized starch
|
||||
DIG Function |
Binding agent; Diluent; Disintegrant
|
||||
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG | ||||||
---|---|---|---|---|---|---|
ICD Disease Classification 01 | Infectious/parasitic disease | Click to Show/Hide | ||||
Ciprofloxacin
|
API Info |
Endocarditis [ICD-11: 1B12]
|
[1] | |||
Bedaquiline
|
API Info |
Pulmonary tuberculosis [ICD-11: 1B10]
|
[2] | |||
ICD Disease Classification 02 | Benign/in-situ/malignant neoplasm | Click to Show/Hide | ||||
Panobinostat
|
API Info |
Multiple myeloma [ICD-11: 2A83]
|
[3] | |||
Tamoxifen
|
API Info |
Breast cancer [ICD-11: 2C60]
|
[4] | |||
Alectinib
|
API Info |
Lung cancer [ICD-11: 2C25]
|
[5] | |||
ICD Disease Classification 05 | Endocrine/nutritional/metabolic disease | Click to Show/Hide | ||||
Atorvastatin
|
API Info |
Hyperlipidaemia [ICD-11: 5C8Z]
|
[6] | |||
Pravastatin
|
API Info |
Dyslipidaemia [ICD-11: 5C81]
|
[7] | |||
Cysteamine
|
API Info |
Nephropathic cystinosis [ICD-11: 5C60]
|
[8] | |||
ICD Disease Classification 06 | Mental/behavioural/neurodevelopmental disorder | Click to Show/Hide | ||||
Fluoxetine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[9] | |||
Cyclobenzaprine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[10] | |||
Trazodone
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[11] | |||
Buprenorphine
|
API Info |
Opiate dependence [ICD-11: 6C43]
|
[12] | |||
Cariprazine
|
API Info |
Bipolar disorder [ICD-11: 6A60]
|
[13] | |||
Lurasidone
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[14] | |||
ICD Disease Classification 08 | Nervous system disease | Click to Show/Hide | ||||
Tiagabine
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[15] | |||
Valbenazine
|
API Info |
Dyskinesia [ICD-11: 8A02]
|
[16] | |||
Pimavanserin
|
API Info |
Parkinsonism [ICD-11: 8A00]
|
[17] | |||
ICD Disease Classification 11 | Circulatory system disease | Click to Show/Hide | ||||
Losartan
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[18] | |||
Benazepril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[19] | |||
Midodrine
|
API Info |
Orthostatic hypotension [ICD-11: BA21]
|
[20] | |||
Labetalol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[21] | |||
Acebutolol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[22] | |||
Disopyramide
|
API Info |
Ventricular tachyarrhythmia [ICD-11: BC71]
|
[23] | |||
Bisoprolol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[24] | |||
Penbutolol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[25] | |||
Dronedarone
|
API Info |
Atrial fibrillation [ICD-11: BC81]
|
[26] | |||
Eprosartan
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[27] | |||
Ivabradine
|
API Info |
Angina pectoris [ICD-11: BA40]
|
[28] | |||
Moexipril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[29] | |||
ICD Disease Classification 12 | Respiratory system disease | Click to Show/Hide | ||||
Fexofenadine
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[30] | |||
Cefpodoxime
|
API Info |
Bronchitis [ICD-11: CA20]
|
[31] | |||
Terbutaline
|
API Info |
Asthma [ICD-11: CA23]
|
[32] | |||
ICD Disease Classification 13 | Digestive system disease | Click to Show/Hide | ||||
Ondansetron
|
API Info |
Gastritis [ICD-11: DA42]
|
[33] | |||
Famotidine
|
API Info |
Peptic ulcer [ICD-11: DA61]
|
[34] | |||
Chenodeoxycholic acid
|
API Info |
Cholelithiasis [ICD-11: DC11]
|
[35] | |||
Rolapitant
|
API Info |
Functional nausea/vomiting [ICD-11: DD90]
|
[36] | |||
ICD Disease Classification 15 | Musculoskeletal/connective-tissue disease | Click to Show/Hide | ||||
Tolmetin
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[37] | |||
Raloxifene
|
API Info |
Osteoporosis [ICD-11: FB83]
|
[38] | |||
ICD Disease Classification 16 | Genitourinary system disease | Click to Show/Hide | ||||
Terazosin
|
API Info |
Prostatic hyperplasia [ICD-11: GA90]
|
[39] | |||
Prazosin
|
API Info |
Prostatic hyperplasia [ICD-11: GA90]
|
[40] | |||
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG | ||||||
---|---|---|---|---|---|---|
Oxidoreductase (ORase) | ||||||
DBT Name: Albendazole monooxygenase (CYP3A4) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | Protein expression downregulation (tested by experiment) | [41] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP3A4_HUMAN | |||||
Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | Protein expression downregulation (tested by experiment) | [41] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP3A4_HUMAN | |||||
Primary active transporter (PAT) | ||||||
DBT Name: Multidrug resistance protein 1 (ABCB1) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | Protein expression downregulation (tested by experiment) | [41] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | MDR1_HUMAN | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.